[PDF][PDF] Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma

M Ni Chroinin, IR Greenstone, A Danish… - … Database Syst Rev, 2005 - health.utah.edu
Studies were assessed independently by two review authors for methodological quality and
data extraction. Confirmation was obtained from the trialists when possible. The primary …

[HTML][HTML] An international comparison of asthma, wheeze, and breathing medication use among children

JA Lawson, G Brozek, A Shpakou, O Fedortsiv… - Respiratory …, 2017 - Elsevier
Background There is variation in childhood asthma between countries with typically higher
prevalence in “Westernized” nations. We compared asthma, respiratory symptoms, and …

Safety of the newer inhaled corticosteroids in childhood asthma

TL Randell, KC Donaghue, GR Ambler, CT Cowell… - Pediatric Drugs, 2003 - Springer
Inhaled corticosteroids (ICS) remain a vital part of the management of persistent asthma, but
concerns have been raised about their potential adverse effects in children. This review …

Drugs associated with adverse events in children and adolescents

WJ Lee, TA Lee, AS Pickard, RN Caskey… - … : The Journal of …, 2014 - Wiley Online Library
Objective To describe the suspected medications, types of reactions, and outcomes of
adverse events (AE s) most commonly reported to the United States Food and Drug …

Guideline-defining asthma clinical trials of the national heart, lung, and blood institute's asthma clinical research network and childhood asthma research and …

LC Denlinger, CA Sorkness, VM Chinchilli… - Journal of Allergy and …, 2007 - Elsevier
Because of an increasing prevalence, morbidity, and mortality associated with asthma, the
National Heart, Lung, and Blood Institute created the Asthma Clinical Research Network and …

Pediatric asthma: improving management to reduce cost of care

M Mellon, B Parasuraman - Journal of Managed Care Pharmacy, 2004 - jmcp.org
BACKGROUND: The economic burden of pediatric asthma is substantial, with national
annual health care costs of $3 billion. Successful clinical management of asthma in children …

Paediatric prescribing of asthma drugs in the UK: are we sticking to the guideline?

S Cohen, J Taitz, A Jaffé - Archives of disease in childhood, 2007 - adc.bmj.com
Background: Asthma guidelines should lead to improved, more rational asthma medication
prescribing. The aims of this study were to assess trends in paediatric asthma drug …

Paediatric asthma exacerbation admissions and stringency of non‐pharmaceutical interventions: Results from a developing country

JW Alsulaiman, KA Kheirallah, MJ Ajlony… - … Journal of Clinical …, 2021 - Wiley Online Library
Background Non‐pharmaceutical interventions (NPI) mitigation measures implemented to
mitigate COVID‐19 has brought unprecedented global impact. Changes in daily living …

Adverse drug reactions of systemic antihistamines in children in the Netherlands

TW de Vries, F van Hunsel - Archives of disease in childhood, 2016 - adc.bmj.com
Background Antihistamines are used for the treatment of allergic rhinitis, allergic
conjunctivitis, chronic spontaneous urticaria and atopic eczema. Objective To study the …

Asthma control in children and adolescents: a study in clinical practice

A Licari, G Marseglia, MA Tosca, G Ciprandi - Journal of Asthma, 2020 - Taylor & Francis
It is well known that uncontrolled asthma should be carefully identified as it represents a risk
factor for asthma exacerbation, poor prognosis, and lung function worsening (1). The 2018 …